According to IMARC Group, the global gaucher disease market size reached USD 1.9 Billion in 2025 and is projected to reach USD 3.1 Billion by 2034, expanding at a CAGR of 5.76% during 2026–2034. This steady gaucher disease market growth reflects the increasing prevalence of genetic abnormalities, expanded access to rare disease therapies, and intensifying R&D pipelines targeting unmet...